88
Views
1
CrossRef citations to date
0
Altmetric
Health Economics

Perspectives of Allergists/Immunologists on the 2009–2010 H1N1 Vaccination Effort

, M.P.H., , M.P.H. & , M.D., M.P.H.
Pages 184-189 | Published online: 02 Feb 2012
 

Abstract

Background. Persons with high-risk conditions such as asthma were a target group for national H1N1 vaccine recommendations. Allergists/immunologists (allergists) are a provider group that could vaccinate persons with asthma and other high-risk conditions. Their level of participation in and experiences with the 2009–2010 H1N1 vaccination campaign are unknown. Objective. To describe the experiences of allergists related to the 2009–2010 H1N1 vaccination campaign. Methods. A cross-sectional, mailed survey of a national sample of 1955 allergists providing outpatient care was conducted in June–September 2010. Results. The overall response rate was 72%. Most allergists “strongly recommended” H1N1 vaccine for children, and most “recommended” or “strongly recommended” vaccine for adults. The majority (71%) agreed to participate in the H1N1 vaccine campaign and received vaccine. Vaccine supply was a significant challenge, but otherwise few major problems were experienced with administering H1N1 vaccine. The majority of respondents, particularly among those who participated in the 2009–2010 H1N1 vaccination campaign, felt they would be very likely to vaccinate in the event of future influenza pandemic. Conclusions. The experiences of allergists in the H1N1 vaccine campaign were generally positive. Most allergists are willing to serve as vaccinators in future influenza pandemics, which will help facilitate broad access to vaccine for patients with asthma and other high-risk conditions.

Acknowledgements

This study was funded by the CDC through a cooperative agreement with the Association of Prevention Teaching and Research.

Declaration of Interest

The findings are those of the authors and do not represent an official viewpoint of the CDC. The authors have no other funding relationships relevant to this work, nor any other potential conflicts of interest to declare.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.